Pixium Vision
A bioelectronics company that developed bionic vision systems for retinal diseases.
ALPIX | PA
Overview
Corporate Details
- ISIN(s):
- FR0011950641 (+1 more)
- LEI:
- 96950046OPLRLKKEOO08
- Country:
- France
- Address:
- 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12
- Website:
- https://www.pixium-vision.com/
- Sector:
- Manufacturing
Description
Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-02 14:00 |
Pixium Vision announces the rejection of the sale plan (plan de cession) by the…
|
English | 156.7 KB | ||
| 2024-02-02 14:00 |
Pixium Vision annonce le rejet du plan de cession par le Tribunal et la convers…
|
French | 165.4 KB | ||
| 2024-01-17 17:00 |
Postponement of the decision on the adoption of a sale plan (plan de cession) a…
|
English | 157.2 KB | ||
| 2024-01-17 17:00 |
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d…
|
French | 165.3 KB | ||
| 2024-01-17 07:00 |
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d…
|
French | 164.0 KB | ||
| 2024-01-17 07:00 |
Postponement of the decision on the adoption of a sale plan (plan de cession) a…
|
English | 156.4 KB | ||
| 2023-12-18 19:00 |
Decision concerning the adoption of a sale plan (plan de cession) and the openi…
|
English | 157.8 KB | ||
| 2023-12-18 19:00 |
Décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédur…
|
French | 166.4 KB | ||
| 2023-12-04 07:00 |
Audience d’examen de l’offre de reprise par le Tribunal de commerce prévue le 1…
|
French | 167.1 KB | ||
| 2023-12-04 07:00 |
Commercial Court hearing to examine the takeover offer scheduled for December 1…
|
English | 156.6 KB | ||
| 2023-11-20 17:45 |
Point sur la procédure de redressement judiciaire : dépôt d’une offre de repris…
|
French | 165.4 KB | ||
| 2023-11-20 17:45 |
Update on the receivership proceedings: submission of a takeover offer to the c…
|
English | 180.7 KB | ||
| 2023-11-14 07:00 |
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique…
|
French | 284.3 KB | ||
| 2023-11-14 07:00 |
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
|
English | 263.7 KB | ||
| 2023-11-13 20:00 |
Pixium Vision annonce la conversion de sa procédure de sauvegarde en redresseme…
|
French | 167.8 KB |
Automate Your Workflow. Get a real-time feed of all Pixium Vision filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pixium Vision
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pixium Vision via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Sell | 42,681 | 16,517.55 EUR |
| 2024-01-09 | N/A | Other | Sell | 80,325 | 45,608.54 EUR |
| 2024-01-08 | N/A | Other | Sell | 110,740 | 69,732.98 EUR |
| 2023-12-04 | N/A | Other | Sell | 665 | 60.98 EUR |
Peer Companies
/other/Spermosens_AB_publ-logo.jpg){kind=logo}